SEC Form 4 reporting owner

Liptak Vincent Paul

Liptak Vincent Paul has filed 4 Form 4 transactions reported between August 6, 2026 and August 10, 2026, as General Counsel of BlossomHill Therapeutics, Inc..

Name as filed: Liptak Vincent Paul

Open-market buys, 24 mo
$75K
2 lines
Open-market sales, 24 mo
None
reported
Companies
1
with Form 4 filings
Latest transaction
Aug 10, 2026
transaction date

Roles and reported holdings

  • BLSMBlossomHill Therapeutics, Inc.
    Aug 6, 2026 – Aug 10, 2026

    General Counsel

    Held directly111,412 sh as of Aug 10, 2026 · Form 4

    24 months: $75K bought

Transaction history

All 4 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Aug 10, 2026BLSMGeneral CounselConversion of derivativeCode C · indirect22,687—Form 4
Aug 10, 2026BLSMGeneral CounselOpen-market purchaseCode P · direct2,200$35K@ $16.00Form 4
Aug 7, 2026BLSMGeneral CounselOpen-market purchaseCode P · direct2,500$40K@ $15.80Form 4
Aug 6, 2026BLSMGeneral CounselGrant or awardCode A · direct46,561—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.